BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 18441325)

  • 1. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells.
    Bourguignon LY; Peyrollier K; Xia W; Gilad E
    J Biol Chem; 2008 Jun; 283(25):17635-51. PubMed ID: 18441325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
    Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
    J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.
    Bourguignon LY; Earle C; Wong G; Spevak CC; Krueger K
    Oncogene; 2012 Jan; 31(2):149-60. PubMed ID: 21685938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells.
    Bourguignon LYW; Xia W; Wong G
    J Biol Chem; 2009 Jan; 284(5):2657-2671. PubMed ID: 19047049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells.
    Bourguignon LY; Peyrollier K; Gilad E; Brightman A
    J Biol Chem; 2007 Jan; 282(2):1265-80. PubMed ID: 17092940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil.
    Nandi SK; Roychowdhury T; Chattopadhyay S; Basu S; Chatterjee K; Choudhury P; Banerjee N; Saha P; Mukhopadhyay S; Mukhopadhyay A; Bhattacharya R
    Toxicol Appl Pharmacol; 2022 Feb; 437():115887. PubMed ID: 35063459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.
    Bourguignon LY; Gilad E; Rothman K; Peyrollier K
    J Biol Chem; 2005 Mar; 280(12):11961-72. PubMed ID: 15655247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
    Bourguignon LY; Gilad E; Peyrollier K
    J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration.
    Bourguignon LY; Zhu H; Shao L; Chen YW
    J Biol Chem; 2001 Mar; 276(10):7327-36. PubMed ID: 11084024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
    Bourguignon LY; Singleton PA; Zhu H; Zhou B
    J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
    Bourguignon LY; Shiina M; Li JJ
    Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
    Bourguignon LY; Singleton PA; Zhu H; Diedrich F
    J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.
    Ricciardelli C; Ween MP; Lokman NA; Tan IA; Pyragius CE; Oehler MK
    BMC Cancer; 2013 Oct; 13():476. PubMed ID: 24124770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.
    Bourguignon LY; Gilad E; Brightman A; Diedrich F; Singleton P
    J Biol Chem; 2006 May; 281(20):14026-40. PubMed ID: 16565089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
    Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E
    J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.